Your browser doesn't support javascript.
loading
Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale.
Martínez-Martín, Pablo; Rodríguez-Blázquez, Carmen; Arakaki, Tomoko; Arillo, Víctor Campos; Chaná, Pedro; Fernández, William; Garretto, Nélida; Martínez-Castrillo, Juan Carlos; Rodríguez-Violante, Mayela; Serrano-Dueñas, Marcos; Ballesteros, Diego; Rojo-Abuin, Jose Manuel; Chaudhuri, Kallol Ray; Merello, Marcelo.
Afiliação
  • Martínez-Martín P; National Center of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain. Electronic address: pmartinez@isciii.es.
  • Rodríguez-Blázquez C; National Center of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
  • Mario Alvarez; Department of Movement Disorders and Neurodegeneration, CIREN, La Habana, Cuba.
  • Arakaki T; Department of Neurology, Hospital Ramos Mejia, Buenos Aires, Centro Universitario de Neurología de la Universidad de Buenos Aires (UBA), Argentina.
  • Arillo VC; Movement Disorders Unit, Department of Neuroscience, Hospital Xanit International, Benalmádena, Málaga, Spain.
  • Chaná P; CETRAM, Facultad de Ciencias Médicas Universidad de Santiago de Chile, Chile.
  • Fernández W; Movement Disorders Unit, Department of Neurology, Universidad Nacional de Colombia, Bogotá, Colombia.
  • Garretto N; Department of Neurology, Hospital Ramos Mejia, Buenos Aires, Centro Universitario de Neurología de la Universidad de Buenos Aires (UBA), Argentina.
  • Martínez-Castrillo JC; Movement Disorders Unit, Department of Neurology, Hospital Ramon y Cajal, IRYCIS, Madrid, Spain.
  • Rodríguez-Violante M; Movement Disorders Unit, Instituto Nacional de Neurologia y Neurocirugia, Mexico, DF, Mexico.
  • Serrano-Dueñas M; Movement Disorder and Biostatistics Units, Neurological Service, Carlos Andrade Marín Hospital and Medicine Faculty, Pontifical Catholic University of Ecuador, Quito, Ecuador.
  • Ballesteros D; Movement Disorders Section, Raul Carrea Institute for Neurological Research (FLENI), Buenos Aires, Argentina.
  • Rojo-Abuin JM; Department of Statistics, Centre of Human and Social Sciences, Spanish Council for Scientific Research, Madrid, Spain.
  • Chaudhuri KR; National Parkinson Foundation International Centre of Excellence, King's College Hospital, King's College, London.
  • Merello M; Movement Disorders Section, Raul Carrea Institute for Neurological Research (FLENI), Buenos Aires, Argentina.
Parkinsonism Relat Disord ; 21(1): 50-4, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25466406
ABSTRACT

BACKGROUND:

Severity of PD is usually assessed by means of the motor and disability-based Hoehn and Yahr staging (HY), or clinician and patient global perceptions. Scores of more detailed assessments, as the MDS-UPDRS, have not been translated to a grading that allows assignment of score sections to severity levels. The objective of the present study is to determine cut-off points for PD severity levels based on the MDS-UPDRS.

METHODS:

International, observational study. Applied assessments were HY, MDS-UPDRS, Clinical Impression for Severity Index, and Clinical and Patient Global Impression of Severity. The coincidence in severity level (mild, moderate, severe) of at least two clinical classifications plus the patient's gradation was considered "the criterion of severity". Cut-off values for each MDS-UPDRS subscale was determined by triangulation of 1) percentile 90 of the subscale total score; 2) receiver operating characteristic (ROC) analysis; and 3) ordinal logistic regression (OLR) model.

RESULTS:

Sample was composed of 452 consecutive PD patients without dementia, 55.3% males, age 65.1 ± 10.7 years and PD duration 8.7 ± 6.3 years. All HY stages were represented. The "criterion", classified 275 patients (60.8% of the sample) as mild PD, 149 (54.2%); moderate, 82 (29.8%); and severe, 44 (16%). The following MDS-UPDRS cut-off points between mild/moderate and moderate/severe levels were found Part 1 10/11 and 21/22; Part 2 12/13 and 29/30; Part 3 32/33 and 58/59; and Part 4 4/5 and 12/13.

CONCLUSION:

Cut-off points to classify PD patients as mild, moderate, or severe on the basis of their MDS-UPDRS scores are proposed.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Índice de Gravidade de Doença Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Índice de Gravidade de Doença Idioma: En Ano de publicação: 2015 Tipo de documento: Article